Impairment by hypoxia or hypoxia/reoxygenation of nitric oxide-mediated relaxation in isolated monkey coronary artery: The role of intracellular superoxide

Journal of Pharmacological Sciences

Volumn 116, Issue 2, 2011, Pages 188-196

  Tawa, Masashi ^a   Yamamizu, Kohei ^b   Geddawy, Ayman ^a   Shimosato, Takashi ^a   Imamura, Takeshi ^a   Ayajiki, Kazuhide ^c   Okamura, Tomio ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Coronary artery; Hypoxia; Nitric oxide; Reoxygenation; Superoxide

Indexed keywords

8 BROMO CYCLIC GMP; APOCYNIN; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; ISOPRENALINE; ISOSORBIDE DINITRATE; NITRIC OXIDE DONOR; OXIPURINOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROTENONE; SUPEROXIDE DISMUTASE; TEMPOL; XANTHINE OXIDASE;

ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; ENZYME ACTIVITY; FEMALE; HAPLORHINI; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HYPOXIA; INTRACELLULAR SIGNALING; MALE; NONHUMAN; REOXYGENATION; SMOOTH MUSCLE RELAXATION;

EID: 79959354146     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11031FP     Document Type: Article

References (43)

1. Lüscher TF, Richard V, Tschudi M, Yang ZH, Boulanger C. Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol. 1990;15:519-527. (Pubitemid 20061474)
2. Feigl EO. Neural control of coronary blood flow. J Vasc Res. 1998;35:85-92. (Pubitemid 28191774)
3. Lincoln TM, Cornwell TL. Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels. 1991;28:129-137.
4. Saikumar P, Dong Z, Weinberg JM, Venkatachalam MA. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene. 1998;17:3341-3349. (Pubitemid 29043986)
5. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res. 1992;26:101-108.
6. Vedernikov YP, Gräser T, Leisner H, Tiedt N. Effect of hypoxia on endothelium-dependent relaxation of porcine coronary arteries and veins. Biomed Biochim Acta. 1991;50:257-263.
7. Hashimoto M, Close LA, Ishida Y, Paul RJ. Dependence of endothelium-mediated relaxation on oxygen and metabolism in porcine coronary arteries. Am J Physiol. 1993;265:H299-H306. (Pubitemid 23224724)
8. Richard V, Kaeffer N, Tron C, Thuillez C. Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation. 1994;89:1254-1261. (Pubitemid 24076553)
9. Mingone CJ, Gupte SA, Iesaki T, Wolin MS. Hypoxia enhances a cGMP-independent nitric oxide relaxing mechanism in pulmonary arteries. Am J Physiol Lung Cell Mol Physiol. 2003;285:L296-L304. (Pubitemid 36909445)
10. Rubanyi G, Paul RJ. O2-sensitivity of beta adrenergic responsiveness in isolated bovine and porcine coronary arteries. J Pharmacol Exp Ther. 1984;230:692-698. (Pubitemid 14040391)
11. Fukuda S, Toriumi T, Xu H, Kinoshita H, Nishimaki H, Kokubun S, et al. Enhanced beta-receptor-mediated vasorelaxation in hypoxic porcine coronary artery. Am J Physiol. 1999;277:H1447-H1452. (Pubitemid 29522675)
12. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol. 2006;91:807-819. (Pubitemid 44266577)
13. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002;282:C227-C241. (Pubitemid 34663181)
14. Azumi H, Inoue N, Ohashi Y, Terashima M, Mori T, Fujita H, et al. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol. 2002;22:1838-1844. (Pubitemid 35315770)
15. Gao Q, Wolin MS. Effects of hypoxia on relationships between cytosolic and mitochondrial NAD(P)H redox and superoxide generation in coronary arterial smooth muscle. Am J Physiol Heart Circ Physiol. 2008;295:H978-H989.
16. Mohazzab-H KM, Kaminski PM, Fayngersh RP, Wolin MS. Oxygen-elicited responses in calf coronary arteries: role of H2O2 production via NADH-derived superoxide. Am J Physiol. 1996;270:H1044-H1053.
17. Toda N, Kawakami M, Yamazaki M, Okamura T. Comparison of endothelium-dependent responses of monkey cerebral and temporal arteries. Br J Pharmacol. 1991;102:805-810.
18. Shinozaki K, Ayajiki K, Nishio Y, Sugaya T, Kashiwagi A, Okamura T. Evidence for a causal role of the rennin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension. 2004;43:255-262. (Pubitemid 38174184)
19. Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, Przybylowski P, et al. Coronary artery superoxide production and Nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol. 2006;26:333-339. (Pubitemid 43732196)
20. Ahmad M, Kelly MR, Zhao X, Kandhi S, Wolin MS. Roles for Nox4 in the contractile response of bovine pulmonary arteries to hypoxia. Am J Physiol Heart Circ Physiol. 2010;298:H1879-H1888.
21. Toda N. Isolated human coronary arteries in response to vasoconstrictor substances. Am J Physiol. 1983;245:H937-H941. (Pubitemid 14212746)
22. Fujioka H, Ayajiki K, Shinozaki K, Toda N, Okamura T. Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries. Naunyn Schmiedebergs Arch Pharmacol. 2002;366:488-495. (Pubitemid 35244914)
23. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456. (Pubitemid 16097810)
24. Wu L, de Champlain J. Effects of superoxide on signaling pathways in smooth muscle cells from rats. Hypertension. 1999;34:1247-1253. (Pubitemid 30002390)
25. Gerassimou C, Kotanidou A, Zhou Z, Simoes DC, Roussos C, Papapetropoulos A. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species. Br J Pharmacol. 2007;150:1084-1091. (Pubitemid 46625092)
26. Münzel T, Daiber A, Mülsch A. Explaining the phenomenon of nitrate tolerance. Circ Res. 2005;97:618-628. (Pubitemid 41416330)
27. Wenzel P, Hink U, Oelze M, Schuppan S, Schaeuble K, Schildknecht S, et al. Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem. 2007;282:792-799. (Pubitemid 47076617)
28. Minamiyama Y, Takemura S, Hai S, Suehiro S, Okada S. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress. Free Radic Biol Med. 2006;40:808-816. (Pubitemid 43327315)
29. Wolin MS, Gupte SA, Oeckler RA. Superoxide in the vascular system. J Vasc Res. 2002;39:191-207. (Pubitemid 34827787)
30. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24:677-683. (Pubitemid 38451603)
31. Hellsten-Westing Y. Immunohistochemical localization of xanthine oxidase in human cardiac and skeletal muscle. Histochemistry. 1993;100:215-222. (Pubitemid 23285677)
32. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics. 1996;98:103-107. (Pubitemid 26226981)
33. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24:471-478. (Pubitemid 37088172)
34. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res. 2006;71:247-258.
35. Schiffrin EL. Oxidative stress, nitric oxide synthase, and superoxide dismutase. Hypertension. 2008;51:31.
36. Marshall C, Mamary AJ, Verhoeven AJ, Marshall BE. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am J Respir Cell Mol Biol. 1996;15:633-644. (Pubitemid 126440603)
37. i through the mitochondrial ROS-PKCε signaling axis in pulmonary artery smooth muscle cells. Free Radical Biol Med. 2008;45:1223-1231.
38. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87:245-313. (Pubitemid 46209993)
39. Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G, et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factoralpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2003;23:418-424.
40. Gupte SA, Kaminski PM, George S, Kouznestova L, Olson SC, Mathew R, et al. Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction. Am J Physiol Heart Circ Physiol. 2009;296:H1048-H1058.
41. Ryu J, Lee CW, Shin JA, Park CS, Kim JJ, Park SJ, et al. FcγRIIa mediates C-reactive protein-induced inflammatory responses of human vascular smooth muscle cells by activating NADPH oxidase 4. Cardiovasc Res. 2007;75:555-565. (Pubitemid 47080970)
42. Guzik TJ, Chen W, Gongora MC, Guzik B, Lob HE, Mangalat D, et al. Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol. 2008;52:1803-1809.
43. Mittal M, Roth M, König P, Hofmann S, Dony E, Goyal P, et al. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res. 2007;101:258-267. (Pubitemid 47344075)